FREE Shippingto US, AU, UK and EU on all orders over $149
/

Zinerit powder for 30 ml of the solution (the external application)

$29.00

9d811b768874

Description

Instruction for medical use of the drug SINNERITE (ZINERYT)

Registration number: P No. 013569/01

Trade name: SINNERITE

Dosage form: powder for preparation of solution for external use complete with solvent and the applicator.

Ingredients: Packing of drug represents two bottles, one of which contains active agents in the form of powder, and another auxiliary components in the form of solution. Before mixing the contents of bottles have the following Ingredients:

Active agents
(in the first bottle)
Nominal
quantity (mg / 30 ml)
* Quantity
taking into account 3.35%
* Quantity
taking into account 5%

Erythromycin of 100% (Ph.Eur.)

1200 1240 1302

Zinc acetate the dihydrate
micronized (Ph.Eur.)

360,0 372,0 389,4

Auxiliary components
(in the second bottle)
Nominal
quantity (mg / 30 ml)

Diisopropyl sebakat
(monograph)
7.81 (8.36 ml)

Ethanol (Ph.Eur.)
17.1 (21.6 ml)

1 ml of the prepared drug
has the following Ingredients:

Erythromycin of 100
% 40 mg

of Zinc acetate the dihydrate micronized
12 mg

Diisopropyl sebakat
0.25 g

Ethanol
of 0.55 g

* amount of active components, erythromycin and zinc of acetate of a dihydrate it is increased by 3.35% for the purpose of compensation of their concentration at preparation of ready drug which nominal volume increases when mixing active components with solvent (each 1000 mg of powder are equivalent to 0.79 ml).

** additional increase in amount of active components, erythromycin and zinc of acetate of a dihydrate, by 5% is connected with maintaining the stated concentration of ready drug at storage.

Description: colourless transparent liquid

Pharmacotherapeutic group: rashes acne remedy

Code of automatic telephone exchange: [D10AF52]

Pharmacological

Pharmacodynamics Sinnerite properties erythromycin-zinc complex. Has anti-inflammatory, antimicrobial effect and komedonolitichesky action.

Erythromycin affects bacteriostatically the microorganisms causing acne rash: Propiombacterium acne and Streptococcus epidermidis. Zinc reduces production of secretion of sebaceous glands, has the knitting effect.

Pharmakokinektika

Complex communication of components of drug provides good penetration into skin of active agents. Zinc generally contacts a follicular epithelium and does not rezorbirutsya in a system blood stream. An insignificant part of erythromycin is exposed to system distribution and further is brought out of an organism.

A way of preparation of solution

Packing contains 2 bottles and the applicator with a soft surface.

Remove caps from both bottles. Do not throw out a cover from a bottle with powder. Pour solution (B) in a bottle with powder (A) and screw up a cover. The empty bottle In can be thrown out. At once carefully shake up bottle contents within one minute. Uncover a bottle. Remove the applicator from packing. Push the applicator in a neck of a bottle and twirl a cover. Drug is ready to use

Duration of a course of 10-12 weeks.
In some cases perhaps clinical improvement in 2 weeks.

Indications

treatment of acne rash.

Contraindications

hypersensitivity to erythromycin and other macroleads,
hypersensitivity to zinc.

Route of administration and doses

Outwardly. By means of the enclosed applicator Sinnerite apply with a thin layer on an affected area of skin 2 times a day: in the morning (before drawing a make-up) and in the evening (after washing). It is necessary to apply drug by a bottle inclination with the prepared solution down, with easy pressing. Speed of putting solution is regulated by force of pressing of the applicator skin. Approximate single dose of 0.5 ml. After drying, solution becomes invisible.

Duration of a course is 10-12 weeks.
In some cases perhaps clinical improvement in 2 weeks.

Collateral deystviyemestny reactions: there can sometimes be a burning sensation, irritation, dryness of integuments in the site of application of drug (as a rule, these phenomena are mild and do not demand drug withdrawal and/or performing symptomatic therapy).

Interaction with others medicinal sredstvamido the present is not established clinically significant interactions of Sinnerite with other medicines.

The overdose preparatasluchayny overdose is improbable because of features of topical administration of drug.

Special ukazaniyasledut to consider a likelihood of development of cross resistance to other macroleads, lincomycin, clindamycin. It is necessary to avoid hit in eyes, on a mucous membrane of an oral cavity and a nose (the irritation or a burn is possible).

Pregnancy and laktatsiyav the present is established that use of drug during the periods of pregnancy and a lactation (breastfeeding) according to indications in the recommended doses is possible.

A form vypuskaporoshok for preparation of solution for external use complete with solvent in bottles on 30 ml and the applicator in a cardboard pack with the instruction for use.

Storage conditions: At a temperature from 15 to 25C, out of children’s reach.

Expiration date: 3 years. Not to apply after expiry date.

Prescription status: Without prescription.

Owner of the registration certificate: Astellas of Pharm B.V. Europe, Netherlands Silviusveg 62, 2333 VE Leiden, Netherlands.

Producer: Astellas of Pharm B.V. Europe, Netherlands.

Production site address: Hogemaat 2, 7942 JG Meppel, Netherlands.

The releasing quality control: Astellas of Pharm B.V. Europe, Netherlands.

Claims on quality are accepted by Representative office in Moscow: Address of Representative office Astellas of Pharm B.V. Europe (Netherlands): 109147, Moscow, Marksistskaya 16 Mosalarko St. Plaza-1 business center, floor 3. Phone number: +7 (495) 737-07-55,

Reviews

There are no reviews yet.

Be the first to review “Zinerit powder for 30 ml of the solution (the external application)”

Your email address will not be published. Required fields are marked *

Wishlist 0
Open wishlist page Continue shopping